Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy.
Sahera Dirajlal-FargoGrace A McComseyPublished in: Current HIV/AIDS reports (2021)
Data highlight the continued risks of subclinical cardiometabolic complications in PHIV in the setting of newer ART. Novel techniques in imaging and omics may help identify early cardiometabolic abnormalities in this young population and potentially identify early changes in the mechanistic pathways related to these changes. Further studies to determine risk and management strategies of the cardiometabolic effects in PHIV adolescents, beyond ART, are warranted. Focus should be on prevention of these complications in youth to avoid new epidemic of diabetes and cardiovascular disease when these youths become aging adults.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- cardiovascular disease
- human immunodeficiency virus
- hiv infected patients
- hiv aids
- young adults
- physical activity
- type diabetes
- risk factors
- mental health
- high resolution
- single cell
- big data
- glycemic control
- deep learning
- hepatitis c virus
- coronary artery disease
- climate change
- adipose tissue